FHIR IG analytics| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | ValueSet-2.16.840.1.113762.1.4.1196.491.json |
| FHIR Version | R4 |
| Source | https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1196.491/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.491 |
| Version | 20210909 |
| Status | active |
| Date | 2021-09-09T01:00:51-04:00 |
| Name | MediumDoseICSFormoterolPreparations |
| Title | Medium Dose ICS Formoterol Preparations |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: This valueset contains oral inhaled corticosteroid preparations in combination with formoterol that are used for medium-dose single maintenance and reliever therapy (SMART) in asthmatic adults and children at least 4 years old.),(Data Element Scope: FHIR MedicationStatement.medicationCodeableConcept, MedicationRequest.medicationCodeableConcept),(Inclusion Criteria: Includes oral ICS-formoterol preparations that might reasonably be used to treat asthmatic children age 4+ years and adults with daily and PRN combination medium-dose ICS-formoterol as per Step 4 in the NHLBI NAEPP 2020 Focused Updates to the Asthma Management Guidelines. The medium-dose range refers to the ICS component as per the NHLBI NAEPP EPR3 Guidelines for the Diagnosis and Management of Asthma (2007). Maintenance ICS ranges are different for age 12+ yrs vs. younger asthmatics, but medium-dose ranges are easily satisfied with the included preparations, which include formoterol in combination with budesonide 160 mcg/actuation (0.16 mg/actuation) and formoterol in combination with mometasone 200 mcg/actuation (0.2 mg/actuation).),(Exclusion Criteria: Excludes withdrawn preparations and retired codes (although they may still be available from pharmacies until supplies are exhausted); excludes low-dose oral ICS-formoterol preparations that are less likely to be used to treat asthmatics age 4+ in the medium-dose ranges as per the NHLBI NAEPP EPR3 Guidelines for the Diagnosis and Management of Asthma (2007).) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
No narrative content found in resource
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113762.1.4.1196.491",
"meta": {
"versionId": "11",
"lastUpdated": "2023-12-21T17:43:03.000-05:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "Elimu Informatics Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2025-03-10"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2021-09-09"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.491",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113762.1.4.1196.491"
}
],
"version": "20210909",
"name": "MediumDoseICSFormoterolPreparations",
"title": "Medium Dose ICS Formoterol Preparations",
"status": "active",
"experimental": false,
"date": "2021-09-09T01:00:51-04:00",
"publisher": "NHLBI Implementation Science and Health Care Innovation Steward",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: This valueset contains oral inhaled corticosteroid preparations in combination with formoterol that are used for medium-dose single maintenance and reliever therapy (SMART) in asthmatic adults and children at least 4 years old.),(Data Element Scope: FHIR \nMedicationStatement.medicationCodeableConcept, MedicationRequest.medicationCodeableConcept),(Inclusion Criteria: Includes oral ICS-formoterol preparations that might reasonably be used to treat asthmatic children age 4+ years and adults with daily and PRN combination medium-dose ICS-formoterol as per Step 4 in the NHLBI NAEPP 2020 Focused Updates to the Asthma Management Guidelines. The medium-dose range refers to the ICS component as per the NHLBI NAEPP EPR3 Guidelines for the Diagnosis and Management of Asthma (2007). Maintenance ICS ranges are different for age 12+ yrs vs. younger asthmatics, but medium-dose ranges are easily satisfied with the included preparations, which include formoterol in combination with budesonide 160 mcg/actuation (0.16 mg/actuation) and formoterol in combination with mometasone 200 mcg/actuation (0.2 mg/actuation).),(Exclusion Criteria: Excludes withdrawn preparations and retired codes (although they may still be available from pharmacies until supplies are exhausted); excludes low-dose oral ICS-formoterol preparations that are less likely to be used to treat asthmatics age 4+ in the medium-dose ranges as per the NHLBI NAEPP EPR3 Guidelines for the Diagnosis and Management of Asthma (2007).)",
"compose": {
"include": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept": [
{
"code": "1246304",
"display": "120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler"
},
{
"code": "1246306",
"display": "120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler [Symbicort]"
},
{
"code": "1246311",
"display": "120 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler"
},
{
"code": "1246313",
"display": "120 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler [Dulera]"
},
{
"code": "1246316",
"display": "60 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler"
},
{
"code": "1246317",
"display": "60 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler [Symbicort]"
},
{
"code": "1660937",
"display": "60 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler"
},
{
"code": "1660938",
"display": "60 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler [Dulera]"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:808fd908-4495-4ab4-af6e-5f8d2ab205cf",
"timestamp": "2025-05-23T19:13:51-04:00",
"total": 8,
"contains": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1246304",
"display": "120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1246306",
"display": "120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler [Symbicort]"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1246311",
"display": "120 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1246313",
"display": "120 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler [Dulera]"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1246316",
"display": "60 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1246317",
"display": "60 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler [Symbicort]"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1660937",
"display": "60 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1660938",
"display": "60 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler [Dulera]"
}
]
}
}